These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

77 related articles for article (PubMed ID: 5825408)

  • 1. Vaccine against anthrax.
    Br Med J; 1965 Sep; 2(5464):717-8. PubMed ID: 5825408
    [No Abstract]   [Full Text] [Related]  

  • 2. Development of novel vaccines against anthrax in man.
    Stepanov AV; Marinin LI; Pomerantsev AP; Staritsin NA
    J Biotechnol; 1996 Jan; 44(1-3):155-60. PubMed ID: 8717399
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Technology of the production of antigens against soil-borne diseases in Madagascar].
    Fatou-Rakotobe ; Rajaonarison JJ
    Berl Munch Tierarztl Wochenschr; 1996 Jan; 109(1):6-7. PubMed ID: 8593157
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Comparative clinical characteristics of the cutaneous form of anthrax among adults and children vaccinated and unvaccinated with STI vaccine].
    Baĭgel'dieva AB
    Sov Zdravookhr Kirg; 1970; 6():40-3. PubMed ID: 5516219
    [No Abstract]   [Full Text] [Related]  

  • 5. Anthrax vaccination.
    Meldrum KC
    Vet Rec; 1989 Aug; 125(6):136. PubMed ID: 2773257
    [No Abstract]   [Full Text] [Related]  

  • 6. All troops sent to gulf should be randomised to receive anthrax vaccination or placebo.
    Ness AR; Harvey I; Gunnell D; Smith GD
    BMJ; 1998 Apr; 316(7140):1322. PubMed ID: 9554917
    [No Abstract]   [Full Text] [Related]  

  • 7. A synthetic peptide vaccine directed against the 2ß2-2ß3 loop of domain 2 of protective antigen protects rabbits from inhalation anthrax.
    Oscherwitz J; Yu F; Cease KB
    J Immunol; 2010 Sep; 185(6):3661-8. PubMed ID: 20696862
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Selected research problems of anthrax vaccine development].
    Zakowska D; Kocik J; Bartoszcze M
    Przegl Epidemiol; 2009; 63(4):505-12. PubMed ID: 20120948
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Method of evaluating anti-anthrax immunity according to the preventive properties of the sera].
    Burgasov PN; Rozhkov GI
    Zh Mikrobiol Epidemiol Immunobiol; 1972 Jun; 49(6):124-34. PubMed ID: 5071614
    [No Abstract]   [Full Text] [Related]  

  • 10. From the Centers for Disease Control and Prevention. Surveillance for adverse effects associated with anthrax vaccination--US Department of Defense, 1998-2000.
    JAMA; 2000 May 24-31; 283(20):2648-9. PubMed ID: 10847805
    [No Abstract]   [Full Text] [Related]  

  • 11. [The anthrax-protective antigen and its preparation].
    Prokůpek K; Dvorák R; Polácek R
    Vet Med (Praha); 1979 Apr; 24(4):217-24. PubMed ID: 108838
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Surveillance for adverse events associated with anthrax vaccination--U.S. Department of Defense, 1998-2000.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2000 Apr; 49(16):341-5. PubMed ID: 10817479
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficacy of a capsule conjugate vaccine against inhalational anthrax in rabbits and monkeys.
    Chabot DJ; Joyce J; Caulfield M; Cook J; Hepler R; Wang S; Vietri NJ; Ruthel G; Shoop W; Pitt L; Leffel E; Ribot W; Friedlander AM
    Vaccine; 2012 Jan; 30(5):846-52. PubMed ID: 22172509
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Anthrax. Biological and immunological principles of diagnosis and prevention. 4. The dynamics and intensity of skin tests with anthraxin in guinea pigs inoculated with a STI vaccine.
    Shlyakhov EN
    J Hyg Epidemiol Microbiol Immunol; 1970; 14(4):464-8. PubMed ID: 4992904
    [No Abstract]   [Full Text] [Related]  

  • 15. US anthrax-vaccine producer saved for now.
    Morris K
    Lancet; 1998 Feb; 351(9103):657. PubMed ID: 9500344
    [No Abstract]   [Full Text] [Related]  

  • 16. [Preservation of avirulent vaccine against anthrax].
    García-Carrillo C
    Bol Oficina Sanit Panam; 1973 May; 74(5):405-10. PubMed ID: 4267557
    [No Abstract]   [Full Text] [Related]  

  • 17. Development of anthrax DNA vaccines.
    Ferrari ME; Hermanson G; Rolland A
    Curr Opin Mol Ther; 2004 Oct; 6(5):506-12. PubMed ID: 15537052
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CpG oligonucleotides improve the protective immune response induced by the anthrax vaccination of rhesus macaques.
    Klinman DM; Xie H; Little SF; Currie D; Ivins BE
    Vaccine; 2004 Jul; 22(21-22):2881-6. PubMed ID: 15246624
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Chloroplast-derived anthrax and other vaccine antigens: their immunogenic and immunoprotective properties.
    Kamarajugadda S; Daniell H
    Expert Rev Vaccines; 2006 Dec; 5(6):839-49. PubMed ID: 17184221
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Mixed vaccine against bacterial anthrax and symptomatic anthrax].
    Blancou JM
    Rev Elev Med Vet Pays Trop; 1974; 27(2):183-7. PubMed ID: 4219888
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.